Literature DB >> 31527313

CD83 orchestrates immunity toward self and non-self in dendritic cells.

Andreas B Wild1, Lena Krzyzak1, Katrin Peckert1, Lena Stich1, Christine Kuhnt1, Alina Butterhof1, Christine Seitz1, Jochen Mattner2, Niklas Grüner2, Maximilian Gänsbauer2, Martin Purtak2, Didier Soulat2, Thomas H Winkler3, Lars Nitschke3, Elisabeth Zinser1, Alexander Steinkasserer1.   

Abstract

Dendritic cells (DCs) are crucial to balance protective immunity and autoimmune inflammatory processes. Expression of CD83 is a well-established marker for mature DCs, although its physiological role is still not completely understood. Using a DC-specific CD83-conditional KO (CD83ΔDC) mouse, we provide new insights into the function of CD83 within this cell type. Interestingly, CD83-deficient DCs produced drastically increased IL-2 levels and displayed higher expression of the costimulatory molecules CD25 and OX40L, which causes superior induction of antigen-specific T cell responses and compromises Treg suppressive functions. This also directly translates into accelerated immune responses in vivo. Upon Salmonella typhimurium and Listeria monocytogenes infection, CD83ΔDC mice cleared both pathogens more efficiently, and CD83-deficient DCs expressed increased IL-12 levels after bacterial encounter. Using the experimental autoimmune encephalomyelitis model, autoimmune inflammation was dramatically aggravated in CD83ΔDC mice while resolution of inflammation was strongly reduced. This phenotype was associated with increased cell influx into the CNS accompanied by elevated Th17 cell numbers. Concomitantly, CD83ΔDC mice had reduced Treg numbers in peripheral lymphoid organs. In summary, we show that CD83 ablation on DCs results in enhanced immune responses by dysregulating tolerance mechanisms and thereby impairing resolution of inflammation, which also demonstrates high clinical relevance.

Entities:  

Keywords:  Autoimmune diseases; Autoimmunity; Dendritic cells; Inflammation; Tolerance

Year:  2019        PMID: 31527313      PMCID: PMC6824307          DOI: 10.1172/jci.insight.126246

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  62 in total

1.  A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily.

Authors:  L J Zhou; R Schwarting; H M Smith; T F Tedder
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

2.  Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo.

Authors:  Simon Kreiser; Jenny Eckhardt; Christine Kuhnt; Marcello Stein; Lena Krzyzak; Christine Seitz; Christine Tucher; Ilka Knippertz; Christoph Becker; Claudia Günther; Alexander Steinkasserer; Matthias Lechmann
Journal:  Immunobiology       Date:  2014-08-10       Impact factor: 3.144

3.  Dendritic cell membrane CD83 enhances immune responses by boosting intracellular calcium release in T lymphocytes.

Authors:  Mariana Pereira Pinho; Isabella Katz Migliori; Elizabeth Alexandra Flatow; José Alexandre M Barbuto
Journal:  J Leukoc Biol       Date:  2014-01-16       Impact factor: 4.962

4.  CD83 expression is essential for Treg cell differentiation and stability.

Authors:  Marina Doebbeler; Christina Koenig; Lena Krzyzak; Christine Seitz; Andreas Wild; Thomas Ulas; Kevin Baßler; Dmitry Kopelyanskiy; Alina Butterhof; Christine Kuhnt; Simon Kreiser; Lena Stich; Elisabeth Zinser; Ilka Knippertz; Stefan Wirtz; Christin Riegel; Petra Hoffmann; Matthias Edinger; Lars Nitschke; Thomas Winkler; Joachim L Schultze; Alexander Steinkasserer; Matthias Lechmann
Journal:  JCI Insight       Date:  2018-06-07

5.  Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival.

Authors:  Felix Bock; Susanne Rössner; Jasmine Onderka; Matthias Lechmann; Maria Teresa Pallotta; Francesca Fallarino; Louis Boon; Charles Nicolette; Mark A DeBenedette; Irina Y Tcherepanova; Ursula Grohmann; Alexander Steinkasserer; Claus Cursiefen; Elisabeth Zinser
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

Review 6.  Th17 cells, γδ T cells and their interplay in EAE and multiple sclerosis.

Authors:  Aoife M McGinley; Sarah C Edwards; Mathilde Raverdeau; Kingston H G Mills
Journal:  J Autoimmun       Date:  2018-01-21       Impact factor: 7.094

7.  OX40 costimulation turns off Foxp3+ Tregs.

Authors:  Minh Diem Vu; Xiang Xiao; Wenda Gao; Nicolas Degauque; Ming Chen; Alexander Kroemer; Nigel Killeen; Naoto Ishii; Xian Chang Li
Journal:  Blood       Date:  2007-06-15       Impact factor: 22.113

8.  Leukocyte infiltration into spinal cord of EAE mice is attenuated by removal of endothelial leptin signaling.

Authors:  Suidong Ouyang; Hung Hsuchou; Abba J Kastin; Pramod K Mishra; Yuping Wang; Weihong Pan
Journal:  Brain Behav Immun       Date:  2014-02-24       Impact factor: 7.217

9.  A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant Mice.

Authors:  Katrin Regina Helene Packhäuser; Gleyder Roman-Sosa; Jens Ehrhardt; Diana Krüger; Marek Zygmunt; Damián Oscar Muzzio
Journal:  Front Immunol       Date:  2017-04-26       Impact factor: 7.561

10.  Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection.

Authors:  Haiyin Liu; Reema Jain; Jing Guan; Vivian Vuong; Satoshi Ishido; Nicole L La Gruta; Daniel H Gray; Jose A Villadangos; Justine D Mintern
Journal:  J Exp Med       Date:  2016-08-08       Impact factor: 14.307

View more
  7 in total

Review 1.  The CD83 Molecule - An Important Immune Checkpoint.

Authors:  Linda Grosche; Ilka Knippertz; Christina König; Dmytro Royzman; Andreas B Wild; Elisabeth Zinser; Heinrich Sticht; Yves A Muller; Alexander Steinkasserer; Matthias Lechmann
Journal:  Front Immunol       Date:  2020-04-17       Impact factor: 7.561

2.  IFNγ, and to a Lesser Extent TNFα, Provokes a Sustained Endothelial Costimulatory Phenotype.

Authors:  Nicole M Valenzuela
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

3.  Bovine Peripheral Blood Derived Lymphocyte Proteome and Secretome Show Divergent Reaction of Bovine Immune Phenotypes after Stimulation with Pokeweed Mitogen.

Authors:  Kristina J H Kleinwort; Roxane L Degroote; Sieglinde Hirmer; Lucia Korbonits; Lea Lorenz; Armin M Scholz; Stefanie M Hauck; Cornelia A Deeg
Journal:  Proteomes       Date:  2022-02-08

4.  The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritis.

Authors:  Dmytro Royzman; Darja Andreev; Lena Stich; Katrin Peckert-Maier; Andreas B Wild; Elisabeth Zinser; Petra Mühl-Zürbes; Evan Jones; Susanne Adam; Silke Frey; Maximilian Fuchs; Meik Kunz; Tobias Bäuerle; Lisa Nagel; Georg Schett; Aline Bozec; Alexander Steinkasserer
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

5.  Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages.

Authors:  Dmytro Royzman; Katrin Peckert-Maier; Lena Stich; Christina König; Andreas B Wild; Miyuki Tauchi; Christian Ostalecki; Franklin Kiesewetter; Stefan Seyferth; Geoffrey Lee; Sabine A Eming; Maximilian Fuchs; Meik Kunz; Ewa K Stürmer; Eva M J Peters; Carola Berking; Elisabeth Zinser; Alexander Steinkasserer
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

Review 6.  Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation.

Authors:  Katrin Peckert-Maier; Dmytro Royzman; Pia Langguth; Anita Marosan; Astrid Strack; Atefeh Sadeghi Shermeh; Alexander Steinkasserer; Elisabeth Zinser; Andreas B Wild
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

Review 7.  Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory Conditions.

Authors:  Kim Doyon-Laliberté; Matheus Aranguren; Johanne Poudrier; Michel Roger
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.